(Q48422478)

11 February 2018

meta-analysis

0 references

title

Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease. (English)

1 reference

11 February 2018

0 references

0 references

1 reference

B Schmand

1

1 reference

11 February 2018

H M Huizenga

series ordinal

2

1 reference

11 February 2018

W A van Gool

series ordinal

3

1 reference

11 February 2018

language of work or name

English

0 references

publication date

29 October 2009

1 reference

11 February 2018

published in

Psychological Medicine

1 reference

11 February 2018

volume

40

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

135-145

1 reference

11 February 2018

MRI of hippocampus and entorhinal cortex in mild cognitive impairment: a follow-up study.

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

PET imaging of amyloid deposition in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Brain structural alterations before mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Longitudinal CSF isoprostane and MRI atrophy in the progression to AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Current concepts in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

MRI and CSF studies in the early diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Diagnosing prodromal Alzheimer's disease: role of CSF biochemical markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Useful effect size interpretations for single case research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Ventricular volume and dementia progression in the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Early detection of Alzheimer's disease using neuroimaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Trajectories of brain loss in aging and the development of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Diagnosis of early dementia by the Double Memory Test: encoding specificity improves diagnostic sensitivity and specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Cerebrospinal fluid tau protein and periventricular white matter lesions in patients with mild cognitive impairment: implications for 2 major pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Visual association test to detect early dementia of the Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

CSF markers for incipient Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Imaging is superior to cognitive testing for early diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: a neuroimaging profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Quantitative evidence for neuroanatomic and neuropsychological markers in dementia of the Alzheimer's type

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Population-based neuropathological studies of dementia: design, methods and areas of investigation--a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Increasing CSF phospho-tau levels during cognitive decline and progression to dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Prediction of Alzheimer's disease in mild cognitive impairment: a prospective study in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

CSF Abeta42, Tau and phosphorylated Tau, APOE epsilon4 allele and MCI type in progressive MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Advanced methods in meta-analysis: multivariate approach and meta-regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

How should meta-regression analyses be undertaken and interpreted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Biomarkers of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

Intrathecal inflammation precedes development of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

A comparison of the Addenbrooke's Cognitive Examination (ACE), conventional neuropsychological assessment, and simple MRI-based medial temporal lobe evaluation in the early diagnosis of Alzheimer's disease

21 January 2018

2 references

https://api.crossref.org/works/10.1017%2FS0033291709991516

21 January 2018

https://api.crossref.org/works/10.1017%2FS0033291709991516

7 January 2021

Validation of clinical diagnostic criteria for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

7 January 2021

CSF Abeta42, tau and phosphorylated tau correlate with medial temporal lobe atrophy.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

7 January 2021

Increased tau protein differentiates mild cognitive impairment from geriatric depression and predicts conversion to dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

7 January 2021

Small baseline volume of left hippocampus is associated with subsequent conversion of MCI into dementia: the Göteborg MCI study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291709991516

7 January 2021

10.1017/S0033291709991516

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

19863841

1 reference

11 February 2018